Stock Market

Biotech Insider Sells Stock Amid Market Surge

By Bullbit Editorial · March 30, 2026

• WhatTango Therapeutics insider sold a significant amount of stock
• WhyThe sale may raise concerns about the company's future performance
• SignalThe insider sale could be a negative signal for investors
• TargetThe company's targeted cancer therapies remain a key focus
• RiskThe sale highlights potential risks for investors in the biotech sector

More breaking news →